The efficacy of the Oxford/AstraZeneca vaccine in children is set to be tested in a new clinical trial.Researchers will use 300 volunteers to assess whether the jab – known as the ChAdOx1 nCoV-19 vaccine – will produce a strong immune response in children aged between six and 17.
COVID-19
University of Oxford
AstraZeneca
More than a dozen slum residents in Bhopal, India, say they thought they were being vaccinated for Covid-19. They say they later..
Some 300 volunteers will take part in the first coronavirus vaccination trial on children and young adults aged six to 17.
